Related references
Note: Only part of the references are listed.Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
Zelin Hou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cellular based immunotherapy for primary liver cancer
Yuanyuan Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma
Qi Lu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
Xiao-Yong Huang et al.
MOLECULAR CANCER (2020)
Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection
Hui Li et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Targeting CD73 to augment cancer immunotherapy
Meejeon Roh et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
Gunn Huh et al.
BMC CANCER (2020)
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
Peng-Fei Zhang et al.
MOLECULAR CANCER (2020)
Galectin-8 in the onset of the immune response and inflammation
Maria Tribulatti et al.
GLYCOBIOLOGY (2020)
The Landscape of Circular RNA in Cancer
Josh N. Vo et al.
CELL (2019)
Genome-wide identification of cancer-specific alternative splicing in circRNA
Jing Feng et al.
MOLECULAR CANCER (2019)
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression
Peng-Fei Zhang et al.
MOLECULAR CANCER (2019)
Potential of CD73 as a target for cancer immunotherapy
Farhad Jadidi-Niaragh
IMMUNOTHERAPY (2019)
CD73 as a potential opportunity for cancer immunotherapy
Ghasem Ghalamfarsa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
Jian Yu et al.
JOURNAL OF HEPATOLOGY (2018)
Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
Rui Peng et al.
CANCER MEDICINE (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
The Biogenesis, Functions, and Challenges of Circular RNAs
Xiang Li et al.
MOLECULAR CELL (2018)
Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
Rui Peng et al.
ONCOTARGETS AND THERAPY (2017)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma
Lucas M. Boehm et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma Systematic Review and Meta-analysis
Michael N. Mavros et al.
JAMA SURGERY (2014)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
D. Sia et al.
ONCOGENE (2013)
Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer
Roger L. Milne et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
ceRNAs: miRNA Target Mimic Mimics
Ignacio Rubio-Somoza et al.
CELL (2011)
Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis
Tae-Hee Um et al.
JOURNAL OF HEPATOLOGY (2011)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
Galectins - Potential targets for cancer therapy
Syed Saif Hasan et al.
CANCER LETTERS (2007)